≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Melanocytic naevi, other sites/unspecified

DOID EFO MESH Endpoint Browser PheWeb

CD2_BENIGN_MELANOCYTIC_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D22.9&
Hospital discharge: ICD-9 216[8-9]A
Cause of death: ICD-10 D22.9&
Cause of death: ICD-9 216[8-9]A

2 out of 7 registries used, show all original rules.

2320

diagram downward connector

Check minimum number of events None

2320

diagram downward connector

Include endpoints None

2320

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

2258

diagram downward connector
CD2_BENIGN_MELANOCYTIC_NOS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D22
Name in latin Naevus melanocyticus non specificatus

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 2258 1389 869
Unadjusted prevalence (%) 0.55 0.60 0.48
Mean age at first event (years) 51.25 47.14 57.83

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 2.48 [1.04, 5.94] 4.1e-2 113
15 years 0.01 1.29 [0.50, 3.32] 6.0e-1 55
5 years 0.00 2.23 [0.90, 5.53] 8.5e-2 33
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS – Melanocytic naevi, other sites/unspecified
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Melanocytic naevi, other sites/unspecified
after Melanocytic naevi, other sites/unspecified

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Melanocytic naevi, other sites/unspecified

↥

Endpoint not on priority list, no data to show.